Published • loading... • Updated
New €25 Million BioReliance Testing Facility Opens at Merck KGaA Global Headquarters in Germany
MilliporeSigma opened a new €25 million BioReliance® testing facility at the company’s global headquarters in Darmstadt, Germany. The facility expands access to commercial drug substance and drug product release testing as well as stability testing for biopharmaceutical companies developing and commercializing therapies in Europe, according to the company. “As demand for biologics and novel therapies continues to grow, our customers need reliabl…
1 Articles
1 Articles
New €25 Million BioReliance Testing Facility Opens at Merck KGaA Global Headquarters in Germany
MilliporeSigma opened a new €25 million BioReliance® testing facility at the company’s global headquarters in Darmstadt, Germany. The facility expands access to commercial drug substance and drug product release testing as well as stability testing for biopharmaceutical companies developing and commercializing therapies in Europe, according to the company. “As demand for biologics and novel therapies continues to grow, our customers need reliabl…
·New Rochelle, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
